BCD Bioscience
Financing Round
- Series A
Round Led by Symbiosis
BCD Bioscience is creating the world’s first broad library of oligosaccharides with diverse natural structures and linking these structures to their functions as prebiotics and immunomodulators. The Company is using its technology to develop ingredients and therapies for better human and animal health both alone and in partnership with others.
View Website
Modality
- Other
Indication
- Circulatory & Metabolic Disease
Development Status
- Other